全文获取类型
收费全文 | 2806篇 |
免费 | 178篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 28篇 |
儿科学 | 75篇 |
妇产科学 | 33篇 |
基础医学 | 321篇 |
口腔科学 | 56篇 |
临床医学 | 229篇 |
内科学 | 610篇 |
皮肤病学 | 39篇 |
神经病学 | 191篇 |
特种医学 | 136篇 |
外科学 | 331篇 |
综合类 | 74篇 |
一般理论 | 4篇 |
预防医学 | 196篇 |
眼科学 | 162篇 |
药学 | 186篇 |
中国医学 | 8篇 |
肿瘤学 | 323篇 |
出版年
2023年 | 13篇 |
2022年 | 12篇 |
2021年 | 75篇 |
2020年 | 33篇 |
2019年 | 53篇 |
2018年 | 51篇 |
2017年 | 53篇 |
2016年 | 51篇 |
2015年 | 56篇 |
2014年 | 85篇 |
2013年 | 134篇 |
2012年 | 148篇 |
2011年 | 173篇 |
2010年 | 103篇 |
2009年 | 98篇 |
2008年 | 129篇 |
2007年 | 140篇 |
2006年 | 130篇 |
2005年 | 153篇 |
2004年 | 144篇 |
2003年 | 141篇 |
2002年 | 112篇 |
2001年 | 120篇 |
2000年 | 77篇 |
1999年 | 73篇 |
1998年 | 48篇 |
1997年 | 48篇 |
1996年 | 39篇 |
1995年 | 23篇 |
1994年 | 36篇 |
1993年 | 33篇 |
1992年 | 36篇 |
1991年 | 37篇 |
1990年 | 17篇 |
1989年 | 36篇 |
1988年 | 36篇 |
1987年 | 28篇 |
1986年 | 36篇 |
1985年 | 21篇 |
1984年 | 20篇 |
1983年 | 13篇 |
1982年 | 16篇 |
1981年 | 23篇 |
1980年 | 16篇 |
1979年 | 12篇 |
1978年 | 11篇 |
1977年 | 10篇 |
1976年 | 11篇 |
1975年 | 6篇 |
1970年 | 5篇 |
排序方式: 共有3002条查询结果,搜索用时 140 毫秒
41.
Daniel T T Chua Jonathan S T Sham Lucullus H T Leung Gordon K H Au 《Radiotherapy and oncology》2005,77(3):290-294
BACKGROUND AND PURPOSE: To evaluate the treatment outcome in patients with locally recurrent nasopharyngeal carcinoma (NPC) treated with intensity-modulated radiation therapy (IMRT). MATERIALS AND METHODS: Between October 2001 and May 2004, 31 patients with locally recurrent NPC received re-irradiation using IMRT. The rT classification distribution was 3 for rT1, 5 for rT2, 9 for rT3, and 14 for r T4. Median time from first course of radiotherapy to re-irradiation was 51 months. IMRT was performed using step-and-shoot method with nine 4-6 MV photon fields and median prescribed dose was 54 Gy (range: 50-60 Gy). Additional treatments included cisplatin-based induction chemotherapy in 68% and radiosurgery boost with a single dose which ranged from 8.5 to 12.5 Gy in 32%. Median follow-up time was 11 months. RESULTS: After re irradiation, 58% of patients had complete regression of primary tumor. One-year loco-regional progression-free, distant metastasis-free and overall survival rates were 56, 90, and 63%, respectively. Significantly better 1-year local progression-free rate was observed in rT1-3 than r T4 tumor (100 vs. 35%). Grade 3 late toxicities, mostly ototoxicity/cranial neuropathy, occurred in six patients (19%). One-year actuarial rates of late toxicities were 70% for all grades and 25% for Grade 3. CONCLUSION: Our preliminary results showed that good control of rT1-3 NPC can be achieved using IMRT with a dose between 50 and 60 Gy, whereas the outcome for r T4 tumor remained poor. Late toxicities were common but incidence of severe toxicities was relatively low. 相似文献
42.
Kenneth W Yip Joseph D Mocanu P Y Billie Au Gillian T Sleep Dolly Huang Pierre Busson Wen-Chen Yeh Ralph Gilbert Brian O'Sullivan Patrick Gullane Carlo Bastianutto Fei-Fei Liu 《Clinical cancer research》2005,11(22):8131-8144
PURPOSE: A wide variety of tumors depend on the dysregulation of Bcl-2 family proteins for survival. The resulting apoptotic block can often provide a mechanism for resistance to anticancer treatments, such as chemotherapy and radiation. This current study evaluates the efficacy of combining systemically delivered Bcl-2 phosphorothioate antisense (Bcl-2 ASO) and radiation for nasopharyngeal cancer therapy. RESULTS: Antisense uptake was unaffected by 0, 3, or 6 Gy radiation. Radiation decreased the fraction of viable C666-1 cells to 60%, with a further decrease to 40% in combination with Bcl-2 ASO. Despite a modest in vitro effect, Bcl-2 ASO alone caused the regression of established xenograft tumors in mice, extending survival by 15 days in a C666-1 and by 6 days in a C15 model. The survival times for mice treated with both Bcl-2 ASO and radiation increased by 52 days in C666-1 and by 20 days in C15 tumors. This combination resulted in a more-than-additive effect in C666-1 tumors. Less impressive gains observed in C15 tumors might be attributable to higher expression of antiapoptotic Bcl-2 family proteins and limited drug distribution in the tumor. Retreatment of C666-1 tumors with the Bcl-2 ASO-radiation combination, however, was effective, resulting in mice surviving for >80 days relative to untreated controls. CONCLUSIONS: Our results show that the Bcl-2 ASO and radiation combination is a highly potent therapy for nasopharyngeal cancer. Further examination of combination therapy with radiation and other Bcl-2 family-targeted anticancer agents in both preclinical and clinical settings is definitely warranted. 相似文献
43.
44.
45.
46.
47.
48.
49.
50.
Labial adhesions are usually seen in early childhood or in the postmenopausal years, but this clinical entity is rarely seen in the reproductive years. We report a case of labial adhesion with acute urinary retention secondary to Bartholin's abscess in a reproductive‐aged woman with normal menstrual periods. We emphasize the possible occurrence of labial adhesion following Bartholin's abscess in the reproductive years with normal estrogen levels. 相似文献